An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use ...

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

Weight-loss jabs, such as Ozempic, Wegovy and Mounjaro, have quickly earned a glowing global reputation for shifting the ...

Eli Lilly expects to read out results from a study in people with obesity and osteoarthritis of the knee in 2025.

Online pharmacies will now have to employ stricter checks to stop people who are already a healthy weight or have a history ...

Some users experience side-effects such as nausea, diarrhoea and fatigue. Other clinical studies have found that some patients taking weight-loss drugs lose muscle at far faster rates than those ...

The General Pharmaceutical Council (GPhC) have published the new guidance for prescribing weight loss injections such as ...

While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...

Weight-loss drugs have also now been added to the list of “high-risk” medicines requiring extra safeguards. If pharmacists do ...

Amid growing concern of the overuse and misuse of obesity drugs, the UK’s pharmacies regulator rolled out stricter guidelines ...

A charity boss who once tipped the scales at more than 28st says weight-loss injections have changed the way he thinks about ...

Those too slim to be eligible for injections can no longer get prescription without seeing a doctor under new guidance ...